12:00 AM
 | 
Oct 24, 2016
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Biofrontera sales and marketing update

Biofrontera launched Ameluz aminolevulinic acid and the BF-RhodoLED lamp in the U.S. Ameluz is approved as photodynamic therapy therapy (PDT)...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >